FDA inspection
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: FDA inspection ending May 10, 2018
FDA inspection 1053169 · No Action Indicated (NAI) · Tarrytown, NY
Key facts
| Inspection ID | 1053169 |
|---|---|
| Firm | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company |
| FEI number | 1719513 |
| Address | 660 White Plains Rd Ste 250 |
| City | Tarrytown |
| State | NY |
| ZIP | 10591 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | May 10, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data